Calidi Biotherapeutics (CLDI) Stock Climbs After Securing New Patent
Calidi Biotherapeutics, Inc. (NYSE: CLDI) shares experienced a notable increase on the stock charts following the announcement of a new patent award. As of the most recent session, CLDI stock saw an 11.05% rise, reaching $1.81 per share. Strengthening Intellectual Property Portfolio A new patent has been granted to Calidi Biotherapeutics for their revolutionary SuperNova […]